- Home
- Services
- north america
- cancer early
Show results for
Refine by
Cancer Early Services In North America
6 services found
Manufactured by:Grail, Inc. based inMenlo Park, CALIFORNIA (USA)
Assessing the Implementation of an Investigational Multi-Cancer Early Detection Test into Clinical Practice. The PATHFINDER Study is a prospective, multi-center study that will evaluate the implementation of GRAIL’s multi-cancer early detection test into clinical practice. GRAIL’s test is designed to detect and ...
by:Envision Radiology based inColorado Springs, COLORADO (USA)
A mammogram procedure is simply an X-ray image of your breast. Mammography uses a low dose X-ray to look for early signs of breast cancer, such as lumps that are too small to be felt either by yourself or your healthcare provider. A mammogram can also show changes in your breast tissue which could indicate early-stage breast ...
Manufactured by:Grail, Inc. based inMenlo Park, CALIFORNIA (USA)
Evaluation of a New Blood Test for Detecting Multiple Types of Cancer Early. The SUMMIT Study is a prospective, observational, longitudinal, cohort study being conducted in London in the United Kingdom. It is designed to enroll approximately 25,000 men and women age 50 to 77 years who do not have a cancer diagnosis at the time of enrollment. ...
Manufactured by:Grail, Inc. based inMenlo Park, CALIFORNIA (USA)
The STRIVE Study is a prospective, observational, longitudinal, cohort study that has enrolled approximately 100,000 women at the time of their screening mammogram. A subset of the data from STRIVE will be used to help validate GRAIL’s blood test for the early detection of multiple cancer types. Participants completed a health questionnaire and provided a ...
by:Vigilant Biosciences, Inc. based inAustin, TEXAS (USA)
This year alone, oral cancer, including oral cancer, will affect the lives of hundreds of thousands of individuals and their families. ...
Manufactured by:ImCare Biotech, LLC based inDoylestown, PENNSYLVANIA (USA)
Overexpression of a novel apoptosis inhibitor, serine protease inhibitor Kazal (SPIK), has been demonstrated in HCC and other cancer patients. In addition, high levels of SPIK are closely associated with early recurrence in cancer patients following surgical resection. Because recurrence of cancer often implies the immune ...